Adoptive cell transfer (ACT) of purified naive, stem cell memory, and central memory T cell subsets results in superior persistence and antitumor immunity compared with ACT of populations containing more-differentiated effector memory and effector T cells. Despite a clear advantage of the less-differentiated populations, the majority of ACT trials utilize unfractionated T cell subsets. Here, we have challenged the notion that the mere presence of less-differentiated T cells in starting populations used to generate therapeutic T cells is sufficient to convey their desirable attributes. Using both mouse and human cells, we identified a T cell–T cell interaction whereby antigen-experienced subsets directly promote the phenotypic, functional, and metabolic differentiation of naive T cells. This process led to the loss of less-differentiated T cell subsets and resulted in impaired cellular persistence and tumor regression in mouse models following ACT. The T memory–induced conversion of naive T cells was mediated by a nonapoptotic Fas signal, resulting in Akt-driven cellular differentiation. Thus, induction of Fas signaling enhanced T cell differentiation and impaired antitumor immunity, while Fas signaling blockade preserved the antitumor efficacy of naive cells within mixed populations. These findings reveal that T cell subsets can synchronize their differentiation state in a process similar to quorum sensing in unicellular organisms and suggest that disruption of this quorum-like behavior among T cells has potential to enhance T cell–based immunotherapies.
Christopher A. Klebanoff, Christopher D. Scott, Anthony J. Leonardi, Tori N. Yamamoto, Anthony C. Cruz, Claudia Ouyang, Madhu Ramaswamy, Rahul Roychoudhuri, Yun Ji, Robert L. Eil, Madhusudhanan Sukumar, Joseph G. Crompton, Douglas C. Palmer, Zachary A. Borman, David Clever, Stacy K. Thomas, Shashankkumar Patel, Zhiya Yu, Pawel Muranski, Hui Liu, Ena Wang, Francesco M. Marincola, Alena Gros, Luca Gattinoni, Steven A. Rosenberg, Richard M. Siegel, Nicholas P. Restifo
Title and authors | Publication | Year |
---|---|---|
Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy
Tzaban S, Stern O, Zisman E, Eisenberg G, Klein S, Frankenburg S, Lotem M |
Frontiers in Immunology | 2025 |
Novel Assignment of Gene Markers to Hematological and Immune Cells Based on Single-Cell Transcriptomics
Rosa ED, Alonso-Moreda N, Berral-González A, Sánchez-Luis E, González-Velasco O, Sánchez-Santos JM, Rivas JD |
International Journal of Molecular Sciences | 2025 |
Immunosenescence, Physical Exercise, and their Implications in Tumor Immunity and Immunotherapy
Yu X, Pei W, Li B, Sun S, Li W, Wu Q |
International Journal of Biological Sciences | 2025 |
Systematic review and quantitative meta-analysis of age-dependent human T-lymphocyte homeostasis
Kulesh V, Peskov K, Helmlinger G, Bocharov G |
Frontiers in Immunology | 2025 |
MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis
Lv Y, Gao Y, Di W, Li Z, Shi Y, Hou T, Chen Y, Tian J, Xu M, Su W, Zhang M, Zhong J |
Frontiers in Pharmacology | 2025 |
FLT3L-induced virtual memory CD8 T cells engage the immune system against tumors.
Tu HF, Kung YJ, Lim L, Tao J, Hu MH, Cheng M, Xing D, Wu TC, Hung CF |
Journal of biomedical science | 2024 |
Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma: Where Do We Stand?
Aggeletopoulou I, Kalafateli M, Triantos C |
International journal of molecular sciences | 2024 |
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit
Yi F, Cohen T, Zimmerman N, Dündar F, Zumbo P, Eltilib R, Brophy EJ, Arkin H, Feucht J, Gormally MV, Hackett CS, Kropp KN, Etxeberria I, Chandran SS, Park JH, Hsu KC, Sadelain M, Betel D, Klebanoff CA |
2024 | |
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Lo Presti V, Meringa A, Dunnebach E, van Velzen A, Moreira AV, Stam RW, Kotecha RS, Krippner-Heidenreich A, Heidenreich OT, Plantinga M, Cornel A, Sebestyen Z, Kuball J, van Til NP, Nierkens S |
Journal for ImmunoTherapy of Cancer | 2024 |
A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma.
Xu J, Zhang W, Tong J, Liu C, Zhang Q, Cao L, Yu J, Zhou A, Ma J |
Cancer Immunology, Immunotherapy | 2024 |
Functionalized nanowires for miRNA-mediated therapeutic programming of naïve T cells.
Yee Mon KJ, Kim S, Dai Z, West JD, Zhu H, Jain R, Grimson A, Rudd BD, Singh A |
Nature Nanotechnology | 2024 |
Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment
Moraly J, Kondo T, Benzaoui M, DuSold J, Talluri S, Pouzolles MC, Chien C, Dardalhon V, Taylor N |
Molecular Oncology | 2024 |
Recent advancements in improving the efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy for hepatocellular carcinoma.
Ren T, Huang Y |
Naunyn-Schmiedeberg's archives of pharmacology | 2024 |
Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy
Li T, Guo S, Xu C, Zhang M, Lyu C, Xu H, Hou Z, Zhang M, Li X, Ren J, Liu C, Kong D, Hao D, Wang G |
Journal for Immunotherapy of Cancer | 2024 |
Biomaterial-Based Therapeutic Delivery of Immune Cells
Dravid AA, Singh A, García AJ |
Advanced healthcare materials | 2024 |
Rapidly Manufactured CAR-T with Conserved Cell Stemness and Distinctive Cytokine-Secreting Profile Shows Improved Anti-Tumor Efficacy
Tsao ST, Gu M, Xiong Q, Deng Y, Deng T, Fu C, Zhao Z, Zhang H, Liu C, Zhong X, Xiang F, Huang F, Wang H |
Vaccines | 2024 |
Memory stem CD8+T cells in HIV/Mtb mono- and co-infection: characteristics, implications, and clinical significance
Xiao J, Wang F, Yan H, Wang B, Su B, Lu X, Zhang T |
Frontiers in Cellular and Infection Microbiology | 2024 |
Senescent T Cells in Age-Related Diseases
Yu PJ, Zhou M, Liu Y, Du J |
Aging and Disease | 2024 |
Defining a TCF1-expressing progenitor allogeneic CD8 T cell subset in acute graft-versus-host disease
Solhwi Lee, Kunhee Lee, Hyeonjin Bae, Kyungmin Lee, Junghwa Lee, Junhui Ma, Ye Lee, Bo Lee, Woong-Yang Park, Se Im |
Nature Communications | 2023 |
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy
Sharma S, Woods M, Mehta NU, Sauer T, Parikh KS, Schmuck-Henneresse M, Zhang H, Mehta B, Brenner MK, Heslop HE, Rooney CM |
Journal for ImmunoTherapy of Cancer | 2023 |
IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation
Lee J, Lee K, Bae H, Lee K, Lee S, Ma J, Jo K, Kim I, Jee B, Kang M, Im SJ |
Frontiers in immunology | 2023 |
Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment
Wilson JJ, Wei J, Daamen AR, Sears JD, Bechtel E, Mayberry CL, Stafford GA, Bechtold L, Grammer AC, Lipsky PE, Roopenian DC, Chang CH |
iScience | 2023 |
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes
Kapitza L, Ho N, Kerzel T, Frank AM, Thalheimer FB, Jamali A, Schaser T, Buchholz CJ, Hartmann J |
Frontiers in immunology | 2023 |
AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
Sakemura RL, Hefazi M, Cox MJ, Siegler EL, Sinha S, Hansen MJ, Stewart CM, Feigin JM, Roman CM, Schick KJ, Can I, Tapper EE, Horvei P, Adada MM, Bezerra ED, Fonkoua LA, Ruff MW, Forsman CL, Nevala WK, Boysen JC, Tschumper RC, Grand CL, Kuchimanchi KR, Mouritsen L, Foulks JM, Warner SL, Call TG, Parikh SA, Ding W, Kay NE, Kenderian SS |
Cancer immunology research | 2023 |
The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma
Xie Q, Hu C, Luo C |
Journal of Cancer | 2023 |
Cell Granularity Reflects Immune Cell Function and Enables Selection of Lymphocytes with Superior Attributes for Immunotherapy
Wu T, Tan JH, Sin W, Luah YH, Tan SY, Goh M, Birnbaum ME, Chen Q, Cheow LF |
Advanced Science | 2023 |
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies.
Ruella M, Korell F, Porazzi P, Maus MV |
Nature reviews. Drug discovery | 2023 |
DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies
Giardino Torchia ML, Moody G |
Frontiers in immunology | 2023 |
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes
Lee KP, Epstein B, Lake CM, Snow AL |
2023 | |
CAR T-cell manufacturing from naive/stem memory T-lymphocytes enhances antitumor responses while curtailing cytokine release syndrome
Silvia Arcangeli, Camilla Bove, Claudia Mezzanotte, Barbara Camisa, Laura Falcone, Francesco Manfredi, Eugenia Bezzecchi, Rita El Khoury, Rossana Norata, Francesca Sanvito, Maurilio Ponzoni, Beatrice Greco, Marta A Moresco, Matteo G. Carrabba, Fabio Ciceri, Chiara Bonini, Attilio Bondanza, Monica Casucci |
Journal of Clinical Investigation | 2022 |
Knowns and Unknowns about CAR-T Cell Dysfunction
A Titov, Y Kaminskiy, I Ganeeva, E Zmievskaya, A Valiullina, A Rakhmatullina, A Petukhov, R Miftakhova, A Rizvanov, E Bulatov |
Cancers | 2022 |
Interaction of Immune and Cancer Cells
M Klink, I Szulc-Kielbik |
2022 | |
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity
C Funk, S Wang, K Chen, A Waller, A Sharma, C Edgar, V Gupta, S Chandrakasan, J Zoine, A Fedanov, S Raikar, J Koff, C Flowers, S Coma, J Pachter, S Ravindranathan, H Spencer, M Shanmugam, E Waller |
Blood | 2022 |
Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, J Durgin, S Nunez-Cruz, J Patel, J Leferovich, M Pinzone, F Shen, K Cummins, G Plesa, V Cantu, S Reddy, F Bushman, S Gill, U ODoherty, R OConnor, M Milone |
Nature Biomedical Engineering | 2022 |
Understanding the Effects of Age and T-Cell Differentiation on COVID-19 Severity: Implicating a Fas/FasL-mediated Feed-Forward Controller of T-Cell Differentiation
A Leonardi, C Argyropoulos, A Hamdy, R Proenca |
Frontiers in immunology | 2022 |
The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy
Y Fujiwara, T Kato, F Hasegawa, M Sunahara, Y Tsurumaki |
Pharmaceuticals (Basel, Switzerland) | 2022 |
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes
P Shah, M Forget, M Frank, P Jiang, D Sakellariou-Thompson, L Federico, R Khairullah, C Neutzler, I Wistuba, C Chow, Y Long, J Fujimoto, S Lin, A Maitra, M Negrao, K Mitchell, A Weissferdt, A Vaporciyan, T Cascone, J Roth, J Zhang, B Sepesi, D Gibbons, J Heymach, C Haymaker, D McGrail, A Reuben, C Bernatchez |
Journal for ImmunoTherapy of Cancer | 2022 |
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
Zhang C, He J, Liu L, Wang J, Wang S, Liu L, Ge J, Gao L, Gao L, Kong P, Liu Y, Liu J, Han Y, Zhang Y, Sun Z, Ye X, Yin W, Sersch M, Shen L, Cao WW, Zhang X |
Blood Cancer Journal | 2022 |
Cytotoxic Efficiency of Human CD8+ T Cell Memory Subtypes
Knörck A, Schäfer G, Alansary D, Richter J, Thurner L, Hoth M, Schwarz EC |
Frontiers in immunology | 2022 |
HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity
Andrew Nguyen, Louisa Ho, Richard Hogg, Lan Chen, Scott R Walsh, Yonghong Wan |
Journal of Clinical Investigation | 2022 |
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells.
Caël B, Galaine J, Bardey I, Marton C, Fredon M, Biichle S, Poussard M, Godet Y, Angelot-Delettre F, Barisien C, Bésiers C, Adotevi O, Pouthier F, Garnache-Ottou F, Bôle-Richard E |
Cancers | 2022 |
Stem-like T cells and niches: Implications in human health and disease
Yi L, Yang L |
Frontiers in immunology | 2022 |
Super-Resolution Imaging of Fas/CD95 Reorganization Induced by Membrane-Bound Fas Ligand Reveals Nanoscale Clustering Upstream of FADD Recruitment
Frazzette N, Cruz AC, Wu X, Hammer JA, Lippincott-Schwartz J, Siegel RM, Sengupta P |
Cells | 2022 |
High-Intensity Aerobic Exercise Suppresses Cancer Growth by Regulating Skeletal Muscle-Derived Oncogenes and Tumor Suppressors
Jee H, Park E, Hur K, Kang M, Kim Y |
Frontiers in Molecular Biosciences | 2022 |
Anti-Apoptotic c-FLIP Reduces the Anti-Tumour Activity of Chimeric Antigen Receptor T Cells
Tan GM, Poudel A, Ali Hosseini Rad SM, McLellan AD |
Cancers | 2022 |
AKT Isoforms in the Immune Response in Cancer.
Ahmad Z, Somanath PR |
Current topics in microbiology and immunology | 2022 |
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma.
Maldonado-Pérez N, Tristán-Manzano M, Justicia-Lirio P, Martínez-Planes E, Muñoz P, Pavlovic K, Cortijo-Gutiérrez M, Blanco-Benítez C, Castella M, Juan M, Wenes M, Romero P, Molina-Estévez FJ, Marañón C, Herrera C, Benabdellah K, Martin F |
Frontiers in immunology | 2022 |
Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors
Li F, Zhao S, Wei C, Hu Y, Xu T, Xin X, Zhu T, Shang L, Ke S, Zhou J, Xu X, Gao Y, Zhao A, Gao J |
Frontiers in immunology | 2022 |
Challenges of COPD Patients during the COVID-19 Pandemic
Sun SW, Qi C, Xiong XZ |
Pathogens | 2022 |
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
JT Huckaby, E Landoni, TM Jacobs, B Savoldo, G Dotti, SK Lai |
Journal for ImmunoTherapy of Cancer | 2021 |
Improving CAR T-Cell Persistence
V Pietrobon, LA Todd, A Goswami, O Stefanson, Z Yang, F Marincola |
International journal of molecular sciences | 2021 |
Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells
AH M., JC Halpin, M Mollaei, SW Bell, N Hirankarn, AD McLellan |
Cancers | 2021 |
Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
SS Qin, AD Melucci, AC Chacon, PA Prieto |
Cells | 2021 |
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches
M Caforio, E de Billy, BD Angelis, S Iacovelli, C Quintarelli, V Paganelli, V Folgiero |
Cancers | 2021 |
Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
V Hofschröer, K Najder, M Rugi, R Bouazzi, M Cozzolino, A Arcangeli, G Panyi, A Schwab |
Frontiers in pharmacology | 2021 |
A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy
H Ren, K Cao, M Wang |
Frontiers in immunology | 2021 |
Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy
I Vanmeerbeek, DM Borras, J Sprooten, O Bechter, S Tejpar, AD Garg |
Genes and Immunity | 2021 |
Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy
A Pasetto, YC Lu |
Frontiers in immunology | 2021 |
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
S Chandrasekaran, CR Funk, T Kleber, CM Paulos, M Shanmugam, EK Waller |
Frontiers in immunology | 2021 |
PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8+ T cells at the expense of central memory
JL Cannons, AV Villarino, SM Kapnick, S Preite, HY Shih, J Gomez-Rodriguez, Z Kaul, H Shibata, JM Reilley, B Huang, R Handon, IT McBain, S Gossa, T Wu, HC Su, DB McGavern, JJ OShea, PJ McGuire, G Uzel, PL Schwartzberg |
Cell Reports | 2021 |
CD95L and Anti-Tumor Immune Response: Current Understanding and New Evidence
DM Richards, C Merz, C Gieffers, A Krendyukov |
Cancer management and research | 2021 |
Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
G Flores-Mendoza, N Rodríguez-Rodríguez, RM Rubio, IK Madera-Salcedo, F Rosetti, JC Crispín |
Frontiers in immunology | 2021 |
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells
C Marton, P Mercier-Letondal, R Loyon, O Adotévi, C Borg, J Galaine, Y Godet |
Cancer Gene Therapy | 2021 |
Exercise and the immune system: taking steps to improve responses to cancer immunotherapy
MP Gustafson, CM Wheatley-Guy, AC Rosenthal, DA Gastineau, E Katsanis, BD Johnson, RJ Simpson |
Journal for ImmunoTherapy of Cancer | 2021 |
Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Z Yang, L Li, A Turkoz, P Chen, R Harari-Steinfeld, M Bobbin, O Stefanson, H Choi, V Pietrobon, B Alphson, A Goswami, V Balan, A Kearney, D Patel, J Yang, D Inel, V Vinod, A Cesano, B Wang, KH Roh, LS Qi, FM Marincola |
Journal of Translational Medicine | 2021 |
Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL
B Deng, J Pan, Z Liu, S Liu, Y Chen, X Qu, Y Zhang, Y Lin, Y Zhang, X Yu, Z Zhang, X Niu, R Luan, M Ma, X Li, T Liu, , H Niu, AH Chang, C Tong |
Molecular Therapy — Methods & Clinical Development | 2021 |
Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials
S Smirnov, A Petukhov, K Levchuk, S Kulemzin, A Staliarova, K Lepik, O Shuvalov, A Zaritskey, A Daks, O Fedorova |
Frontiers in immunology | 2021 |
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
W Gong, L Wang, S Stock, M Ni, M Schubert, B Neuber, C Kleist, A Hückelhoven-Krauss, D Wu, C Müller-Tidow, A Schmitt, H Shiku, M Schmitt, L Sellner |
Cells | 2021 |
LFA-1 in T cell priming, differentiation, and effector functions
Gerard A, Cope AP, Kemper C, Alon R, Köchl R |
Trends in Immunology | 2021 |
Antigen-specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K. Lundgren, Xuming Mao, Silvio Manfredo-Vieira, Selene Nunez-Cruz, Erik F. Williams, Charles-Antoine Assenmacher, Enrico Radaelli, Sangwook Oh, Baomei Wang, Christoph T. Ellebrecht, Joseph A. Fraietta, Michael C. Miloneǂ, Aimee S. Payne |
Journal of Clinical Investigation | 2020 |
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells
CM Mousset, W Hobo, A de Ligt, S Baardman, NP Schaap, JH Jansen, AB van der Waart, H Dolstra |
Cancer Immunology, Immunotherapy | 2020 |
Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HBV Replication through Production of IFN-γ and TNF-⍺
M Haque, F Lei, X Xiong, Y Ren, A Kumar, JK Das, X Ren, D Fang, P de Figueiredo, JM Yang, J Song |
iScience | 2020 |
Group O plasma as a media supplement for CAR‐T cells and other adoptive T‐cell therapies
RC Nelson, V Fellowes, P Jin, H Liu, SL Highfill, J Ren, J Szymanski, WA Flegel, DF Stroncek |
Transfusion | 2020 |
Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
E Chruściel, Z Urban-Wójciuk, Ł Arcimowicz, M Kurkowiak, J Kowalski, M Gliwiński, T Marjański, W Rzyman, W Biernat, R Dziadziuszko, C Montesano, R Bernardini, N Marek-Trzonkowska |
Cancers | 2020 |
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma
LD Galva, L Cai, Y Shao, Y He |
Journal of genetics and genomics = Yi chuan xue bao | 2020 |
Development of CAR-T cell therapy for B-ALL using a point-of-care approach
L de Macedo Abdo, LR Barros, MS Viegas, LV Marques, P de Sousa Ferreira, L Chicaybam, MH Bonamino |
OncoImmunology | 2020 |
Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer
E Lafont |
Cancers | 2020 |
Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
A Gavriil, M Barisa, E Halliwell, J Anderson |
Cancers | 2020 |
Epigenetic mechanisms underlying HIV-Infection induced susceptibility of CD4+ T cells to enhanced activation-induced FasL expression and cell death
SS Ghare, PM Chilton, AV Rao, S Joshi-Barve, P Peyrani, AR Vega, CJ McClain, K Bryant, RL Cook, M Freiberg, S Barve |
Journal of acquired immune deficiency syndromes (1999) | 2020 |
Memory T cells: strategies for optimizing tumor immunotherapy
Q Liu, Z Sun, L Chen |
Protein & Cell | 2020 |
Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
T Mika, S Ladigan-Badura, A Maghnouj, B Mustafa, S Klein-Scory, A Baraniskin, S Döhring, I Fuchs, S Ehl, SA Hahn, R Schroers |
Frontiers in Oncology | 2020 |
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8 + T cells
CJ Dwyer, DC Arhontoulis, GO Rivera, HM Knochelmann, AS Smith, MM Wyatt, MP Rubinstein, C Atkinson, JE Thaxton, DM Neskey, CM Paulos |
European Journal of Immunology | 2020 |
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
SJ Im, SJ Ha |
Immune Network | 2020 |
Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy
M Feist, Z Zhu, E Dai, C Ma, Z Liu, E Giehl, R Ravindranathan, SJ Kowalsky, N Obermajer, US Kammula, AJ Lee, MT Lotze, ZS Guo, DL Bartlett |
Cancer Gene Therapy | 2020 |
Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19
AJ Leonardi, RB Proenca |
Frontiers in immunology | 2020 |
Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
S Arcangeli, L Falcone, B Camisa, FD Girardi, M Biondi, F Giglio, F Ciceri, C Bonini, A Bondanza, M Casucci |
Frontiers in immunology | 2020 |
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
ME Maccari, S Fuchs, P Kury, G Andrieux, S Völkl, B Bengsch, MR Lorenz, M Heeg, J Rohr, S Jägle, CN Castro, M Groß, U Warthorst, C König, I Fuchs, C Speckmann, J Thalhammer, FG Kapp, MG Seidel, G Dückers, S Schönberger, C Schütz, M Führer, R Kobbe, D Holzinger, C Klemann, P Smisek, S Owens, G Horneff, R Kolb, N Naumann-Bartsch, M Miano, J Staniek, M Rizzi, T Kalina, P Schneider, A Erxleben, R Backofen, A Ekici, CM Niemeyer, K Warnatz, B Grimbacher, H Eibel, A Mackensen, AP Frei, K Schwarz, M Boerries, S Ehl, A Rensing-Ehl |
Journal of Experimental Medicine | 2020 |
Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
M Kroemer, C Turco, L Spehner, J Viot, I Idirène, A Bouard, E Renaude, M Deschamps, Y Godet, O Adotévi, S Limat, B Heyd, M Jary, R Loyon, C Borg |
Journal for ImmunoTherapy of Cancer | 2020 |
Modes of Communication between T Cells and Relevance for Immune Responses
L Uhl, A Gérard |
International journal of molecular sciences | 2020 |
Additional possibilities of chimeric antigen receptor T-cells in B-cell lymphoma: combination therapy
Y Yang, J Zhou, C Cao, P Cai, X Wang, C Chang, J Wang, Q Zhang |
Translational cancer research | 2020 |
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
Tori N. Yamamoto, Ping-Hsien Lee, Suman Kumar Vodnala, Devikala Gurusamy, Rigel Kishton, Zhiya Yu, Arash Eidizadeh, Robert Eil, Jessica Fioravanti, Luca Gattinoni, James N. Kochenderfer, Terry J Fry, Bulent Arman Aksoy, Jeffrey Hammerbacher, Anthony C Cruz, Richard Siegel, Nicholas P. Restifo, Christopher A. Klebanoff |
Journal of Clinical Investigation | 2019 |
Rethinking Communication in the Immune System: The Quorum Sensing Concept
L Antonioli, C Blandizzi, P Pacher, M Guilliams, G Haskó |
Trends in Immunology | 2019 |
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines
CJ Dwyer, HM Knochelmann, AS Smith, MM Wyatt, GO Rivera, DC Arhontoulis, E Bartee, Z Li, MP Rubinstein, CM Paulos |
Frontiers in immunology | 2019 |
Generation and Immune Regulation of CD4+CD25−Foxp3+ T Cells in Chronic Obstructive Pulmonary Disease
JH Wu, M Zhou, Y Jin, ZJ Meng, XZ Xiong, SW Sun, SY Miao, HL Han, XN Tao |
Frontiers in immunology | 2019 |
Emerging Cellular Therapies for Cancer
S Guedan, M Ruella, CH June |
Annual Review of Immunology | 2019 |
TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity
Rossin, Miloro, Hueber |
Cancers | 2019 |
HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma
BW Dai, ZM Yang, P Deng, YR Chen, ZJ He, , S Zhang, HJ Wu, ZH Ren |
Journal of Cancer | 2019 |
T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
SS Chandran, CA Klebanoff |
Immunological Reviews | 2019 |
Aging boosts antiviral CD8+T cell memory through improved engagement of diversified recall response determinants
B Davenport, J Eberlein, TT Nguyen, F Victorino, K Jhun, H Abuirqeba, V van der Heide, P Heeger, D Homann, GF Rall |
PLoS pathogens | 2019 |
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
S Stock, M Schmitt, L Sellner |
International journal of molecular sciences | 2019 |
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells
W Gong, JM Hoffmann, S Stock, L Wang, Y Liu, ML Schubert, B Neuber, A Hückelhoven-Krauss, U Gern, A Schmitt, C Müller-Tidow, H Shiku, M Schmitt, L Sellner |
Cancer Immunology, Immunotherapy | 2019 |
Developing neoantigen-targeted T cell–based treatments for solid tumors
TN Yamamoto, RJ Kishton, NP Restifo |
Nature Medicine | 2019 |
Cell-Based IL-15:IL-15Rα Secreting Vaccine as an Effective Therapy for CT26 Colon Cancer in Mice
Van Anh Do Thi, Hyung Min Jeon, Sang Min Park, Hayyoung Lee, Young Sang Kim |
Molecules and Cells | 2019 |
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
S Ghassemi, S Nunez-Cruz, RS O'Connor, JA Fraietta, PR Patel, J Scholler, DM Barrett, SM Lundh, MM Davis, F Bedoya, C Zhang, J Leferovich, SF Lacey, BL Levine, SA Grupp, CH June, JJ Melenhorst, MC Milone |
Cancer immunology research | 2018 |
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists
CT Petersen, M Hassan, AB Morris, J Jeffery, K Lee, N Jagirdar, AD Staton, SS Raikar, HT Spencer, T Sulchek, CR Flowers, EK Waller |
Blood Advances | 2018 |
Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model
A Contreras, MV Beems, AJ Tatar, S Sen, P Srinand, M Suresh, TK Luther, CS Cho |
Journal for ImmunoTherapy of Cancer | 2018 |
Epigenetic control of CD8+ T cell differentiation
AN Henning, R Roychoudhuri, NP Restifo |
Nature Reviews Immunology | 2018 |
CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
HM Knochelmann, AS Smith, CJ Dwyer, MM Wyatt, S Mehrotra, CM Paulos |
Frontiers in immunology | 2018 |
Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
C Tomuleasa, S Fuji, C Berce, A Onaciu, S Chira, B Petrushev, WT Micu, V Moisoiu, C Osan, C Constantinescu, S Pasca, A Jurj, L Pop, I Berindan-Neagoe, D Dima, S Kitano |
Frontiers in immunology | 2018 |
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
PA Ascierto, J Brugarolas, L Buonaguro, LH Butterfield, D Carbone, B Daniele, R Ferris, BA Fox, J Galon, C Gridelli, HL Kaufman, CA Klebanoff, I Melero, P Nathan, CM Paulos, M Ruella, R Sullivan, H Zarour, I Puzanov |
Journal for ImmunoTherapy of Cancer | 2018 |
Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy
F Yi, N Frazzette, AC Cruz, CA Klebanoff, RM Siegel |
Trends in Molecular Medicine | 2018 |
Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanoma:
KC Foley, MI Nishimura, TV Moore |
Melanoma Research | 2018 |
Silencing stemness in T cell differentiation
AN Henning, CA Klebanoff, NP Restifo |
Science | 2018 |
Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium
AR Medvec, C Ecker, H Kong, EA Winters, J Glover, A Varela-Rohena, JL Riley |
Molecular Therapy — Methods & Clinical Development | 2018 |
A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients
R Khouri, G Silva-Santos, T Dierckx, SM Menezes, D Decanine, K Theys, AC Silva, L Farré, A Bittencourt, M Mangino, M Roederer, AM Vandamme, JV Weyenbergh |
OncoImmunology | 2018 |
Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies
In-Young Jung, Jungmin Lee |
Molecules and Cells | 2018 |
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8 + T cells for adoptive immunotherapy
CM Mousset, W Hobo, Y Ji, H Fredrix, VD Giorgi, RD Allison, MG Kester, JH Falkenburg, NP Schaap, JH Jansen, L Gattinoni, H Dolstra, AB van der Waart |
OncoImmunology | 2018 |
Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation
MF Krummel, JN Mahale, LF Uhl, EA Hardison, AM Mujal, JM Mazet, RJ Weber, ZJ Gartner, A Gérard |
Proceedings of the National Academy of Sciences | 2018 |
CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
KB Long, RM Young, AC Boesteanu, MM Davis, JJ Melenhorst, SF Lacey, DA DeGaramo, BL Levine, JA Fraietta |
Frontiers in immunology | 2018 |
Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells
B Omer, PA Castillo, H Tashiro, T Shum, MT Huynh, M Cardenas, M Tanaka, A Lewis, T Sauer, R Parihar, N Lapteva, M Schmueck-Henneresse, M Mukherjee, S Gottschalk, CM Rooney |
Frontiers in Medicine | 2018 |
Atypical Human Effector/Memory CD4+ T Cells With a Naive-Like Phenotype
N Caccamo, SA Joosten, TH Ottenhoff, F Dieli |
Frontiers in immunology | 2018 |
Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
LL Yan, BN Liu |
OncoTargets and therapy | 2018 |
Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome.
Aresvik DM, Øverland T, Lima K, Pettersen RD, Abrahamsen TG |
Journal of Clinical Immunology | 2018 |
Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
J Zhu, PF Petit, BJ den Eynde |
Cancer Immunology, Immunotherapy | 2018 |
Transient stimulation expands superior antitumor T cells for adoptive therapy
Yuki Kagoya, Munehide Nakatsugawa, Toshiki Ochi, Yuchen Cen, Tingxi Guo, Mark Anczurowski, Kayoko Saso, Marcus Butler, Naoto Hirano |
JCI Insight | 2017 |
Th17 cells are refractory to senescence retaining robust antitumor activity after long-term ex vivo expansion
Jacob Bowers, Michelle H. Nelson, Kinga Majchrzak, Stefanie Bailey, Barbel Rohrer, Andrew Kaiser, Carl Atkinson, Luca Gattinoni, Chrystal Paulos |
JCI Insight | 2017 |
Inhibition of AKT-signaling uncouples T-cell differentiation from expansion for receptor-engineered adoptive immunotherapy
Christopher Klebanoff, Joseph G. Crompton, Anthony Leonardi, Tori Yamamoto, Smita Chandran, Robert Eil, Madhusudhanan Sukumar, Suman Kumar Vodnala, Jinhui Hu, Yun Ji, David Clever, Mary Black, Devikala Gurusamy, Michael Kruhlak, Ping Jin, David Stroncek, Luca Gattinoni, Steven A. Feldman, Nicholas Restifo |
JCI Insight | 2017 |
Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
A Ramadan, B Griesenauer, D Adom, R Kapur, H Hanenberg, C Liu, MH Kaplan, S Paczesny |
Journal of Experimental Medicine | 2017 |
Predictors of responses to immune checkpoint blockade in advanced melanoma
N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, DM Woods, AL Sodré, M Hansen, Y Meirow, M Sade-Feldman, A Burra, SS Kwek, C Flament, M Messaoudene, CP Duong, L Chen, BS Kwon, AC Anderson, VK Kuchroo, B Weide, F Aubin, C Borg, S Dalle, O Beatrix, M Ayyoub, B Balme, G Tomasic, AM di Giacomo, M Maio, D Schadendorf, I Melero, B Dréno, A Khammari, R Dummer, M Levesque, Y Koguchi, L Fong, M Lotem, M Baniyash, H Schmidt, IM Svane, G Kroemer, A Marabelle, S Michiels, A Cavalcanti, MJ Smyth, JS Weber, AM Eggermont, L Zitvogel |
Nature Communications | 2017 |
Protective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1/2 protein released from poly(lactide-co-glycolide) microparticles
SC Chuang, YC Chung, CD Yang |
Parasite | 2017 |
Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases
M Croft, RM Siegel |
Nature Reviews Rheumatology | 2017 |
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
C Fournier, F Martin, L Zitvogel, G Kroemer, L Galluzzi, L Apetoh |
OncoImmunology | 2017 |
PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
JS Bowers, K Majchrzak, MH Nelson, BA Aksoy, MM Wyatt, AS Smith, SR Bailey, LR Neal, JE Hammerbacher, CM Paulos |
Frontiers in immunology | 2017 |
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells
M Schmueck-Henneresse, B Omer, T Shum, H Tashiro, M Mamonkin, N Lapteva, S Sharma, L Rollins, G Dotti, P Reinke, HD Volk, CM Rooney |
Journal of immunology (Baltimore, Md. : 1950) | 2017 |
IL-21 augments rapamycin in expansion of alpha fetoprotein antigen specific stem-cell-like memory T cells in vitro
VT Jeza, X Li, J Chen, Z Liang, AO Aggrey, X Wu |
The Pan African medical journal | 2017 |
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
J Zhu, CG de Tenbossche, S Cané, D Colau, N Baren, C Lurquin, AM Schmitt-Verhulst, P Liljeström, C Uyttenhove, BJ van Eynde |
Nature Communications | 2017 |
Peripheral CD4+ naïve/memory ratio is an independent predictor of survival in non-small cell lung cancer
P Yang, J Ma, X Yang, W Li |
Oncotarget | 2017 |
Novel Immunotherapies for Multiple Myeloma
M DAgostino, M Boccadoro, EL Smith |
Current Hematologic Malignancy Reports | 2017 |
Metastasectomy for Tumor-Infiltrating Lymphocytes: An Emerging Operative Indication in Surgical Oncology
JG Crompton, N Klemen, US Kammula |
Annals of Surgical Oncology | 2017 |
Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity
S He, Y Liu, L Meng, H Sun, Y Wang, Y Ji, J Purushe, P Chen, C Li, J Madzo, JP Issa, J Soboloff, R Reshef, B Moore, L Gattinoni, Y Zhang |
Nature Communications | 2017 |
Multifaceted Role of BTLA in the Control of CD8 + T-cell Fate after Antigen Encounter
K Ritthipichai, CL Haymaker, M Martinez, A Aschenbrenner, X Yi, M Zhang, C Kale, LM Vence, J Roszik, Y Hailemichael, WW Overwijk, N Varadarajan, R Nurieva, LG Radvanyi, P Hwu, C Bernatchez |
Clinical cancer research | 2017 |
Modulation of CD8 + memory stem T cell activity and glycogen synthase kinase 3β inhibition enhances anti-tumoral immunity in gastric cancer
J Zhang, Y Zhao, Y Lv, P Cheng, W Chen, M Duan, Y Teng, T Wang, L Peng, F Mao, Y Liu, X Fu, P Yu, P Luo, W Zhang, Q Zou, Y Zhuang |
OncoImmunology | 2017 |
T memory stem cells in health and disease
L Gattinoni, DE Speiser, M Lichterfeld, C Bonini |
Nature Medicine | 2017 |
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
M Sabatino, J Hu, M Sommariva, S Gautam, V Fellowes, JD Hocker, S Dougherty, H Qin, CA Klebanoff, TJ Fry, RE Gress, JN Kochenderfer, DF Stroncek, Y Ji, L Gattinoni |
Blood | 2016 |
Role of memory T cell subsets for adoptive immunotherapy
DH Busch, SP Fräßle, D Sommermeyer, VR Buchholz, SR Riddell |
Seminars in Immunology | 2016 |
Regulatory circuits of T cell function in cancer
DE Speiser, PC Ho, G Verdeil |
Nature Reviews Immunology | 2016 |
Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells
HH van Acker, S Anguille, Y Willemen, JM van Bergh, ZN Berneman, E Lion, EL Smits, VF van Tendeloo |
Journal of Hematology & Oncology | 2016 |
Immunology: Channelling potassium to fight cancer
KG Chandy, RS Norton |
Nature | 2016 |
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
LV Hurton, H Singh, AM Najjar, KC Switzer, T Mi, S Maiti, S Olivares, B Rabinovich, H Huls, MA Forget, V Datar, P Kebriaei, DA Lee, RE Champlin, LJ Cooper |
Proceedings of the National Academy of Sciences | 2016 |
Driving gene-engineered T cell immunotherapy of cancer
LA Johnson, CH June |
Cell Research | 2016 |
Cell-Intrinsic Barriers of T Cell-Based Immunotherapy
HE Ghoneim, AE Zamora, PG Thomas, BA Youngblood |
Trends in Molecular Medicine | 2016 |
A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies
TL Lu, O Pugach, R Somerville, SA Rosenberg, JN Kochenderfer, M Better, SA Feldman |
Human Gene Therapy Methods | 2016 |
Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction
AC Cruz, M Ramaswamy, C Ouyang, CA Klebanoff, P Sengupta, TN Yamamoto, F Meylan, SK Thomas, N Richoz, R Eil, S Price, R Casellas, VK Rao, J Lippincott-Schwartz, NP Restifo, RM Siegel |
Nature Communications | 2016 |
TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology
F Meylan, RM Siegel |
Seminars in Immunopathology | 2016 |
Selection bias: maintaining less differentiated T cells for adoptive immunotherapy
Yang Xu, Gianpietro Dotti |
Journal of Clinical Investigation | 2015 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |